The mammalian retina contains approximately 30 different morphological types of amacrine cells, receiving glutamatergic input from bipolar cells. In this study, we combined electrophysiological and pharmacological techniques in order to study the glutamate receptors expressed by different types of amacrine cells. Whole-cell currents were recorded from amacrine cells in vertical slices of the mouse retina. During the recordings the cells were filled with Lucifer Yellow0Neurobiotin allowing classification as wide-field or narrow-field amacrine cells. Amacrine cell recordings were also carried out in a transgenic mouse line whose glycinergic amacrine cells express enhanced green fluorescent protein~EGFP!. Agonist-induced currents were elicited by exogenous application of NMDA, AMPA, and kainate~KA! while holding cells at Ϫ75 mV. Using a variety of specific agonists and antagonists~NBQX, AP5, cyclothiazide, GYKI 52466, GYKI 53655, SYM 2081! responses mediated by AMPA, KA, and NMDA receptors could be dissected. All cells~n ϭ 300! showed prominent responses to non-NMDA agonists. Some cells expressed AMPA receptors exclusively and some cells expressed KA receptors exclusively. In the majority of cells both receptor types could be identified. NMDA receptors were observed in about 75% of the wide-field amacrine cells and in less than half of the narrow-field amacrine cells. Our results confirm that different amacrine cell types express distinct sets of ionotropic glutamate receptors, which may be critical in conferring their unique temporal responses to this diverse neuronal class.
Introduction
There are as many as 30 different types of amacrine cells in the mammalian retina~Vaney, 1991; MacNeil & Masland, 1998 !. About half of them are GABAergic while the other half are glycinergic neurons. GABAergic amacrine cells are usually widefield cells and they often release other neuroactive substances in addition to GABA. Glycinergic amacrine cells are mostly smallfield cells with diffuse and sometimes bistratified dendritic trees Pourcho & Goebel 1985; Menger et al., 1998!. Amacrine cells receive synaptic input from bipolar cells and from other amacrine cells. The bipolar cell synapse contains a presynaptic ribbon opposed to two postsynaptic elements and is therefore named a dyad~Dowling & Boycott, 1966!. The two processes postsynaptic to cone bipolar cells are a ganglion cell dendrite and an amacrine cell process. In the case of rod bipolar cells, the two postsynaptic processes are the dendrites of two different types of amacrine cell, the AII and the AI cell~Kolb & Famiglietti 1974; A17 cell in cats, S102 cell in rabbits, Li et al., 2002 !. Bipolar cells release glutamate and the light responses of their postsynaptic ganglion and amacrine cells depend on the type of glutamate receptors~GluRs! they express at the dyad.
Ionotropic GluRs have been subdivided into three major classes: a-amino-3-hydroxy-5-methylisoxazole-4-proprionic acid~AMPA!, kainic acid~KA!, and N-methl-d-aspartate~NMDA! receptors. Molecular cloning has shown that AMPA receptors are complexes of the subunits GluR1, GluR2, GluR3, or GluR4. KA receptors are composed of the subunits GluR5, GluR6, GluR7, KA-1, or KA-2 and NMDA receptors are composed of the subunits NR1, NR2A, NR2B, NR2C, NR2D, and NR3A. In addition, the orphan receptor subunits d1 and d2 are associated with these GluRs~Hollmann & Heinemann, 1994; Ozawa et al., 1998; Dingledine et al., 1999; Kew & Kemp, 2005!. The localization of GluRs in the retina was first studied at the mRNA level by in situ hybridization~Hughes et al., 1992; Müller et al., 1992; Zhang et al., 1996 !. All three classes of GluRs were observed in the amacrine cell layer; however, the resolution of the signals was not sufficient to distinguish different amacrine cell types.
Immunocytochemical staining of the retina with subunit specific antibodies has revealed a clustering of GluRs in postsynaptic densities. The clusters immunostained for the different subunits show characteristic distributions across the inner plexiform layer IPL!, suggesting they are involved with different sets of neurons Hartveit et al., 1994; Peng et al., 1995; Brandstätter et al., 1998; Thoreson & Witkovsky, 1999; Fletcher et al., 2000; Hack et al., 2001; Grünert et al., 2002 !. The two postsynaptic partners at the bipolar cell dyad usually express two different types of GluRs Brandstätter et al., 1994; Qin & Pourcho, 1996 , 1999a 2001!. A more detailed analysis has been performed examining the GluRs postsynaptic to the rod bipolar cell dyad showing that AMPA receptors are localized to the AII cell, while d102 subunits are found on the A17 cell~Ghosh et al., 2001; Li et al., 2002 ! have studied the glutamatergic drive of different neurons in the retina with a channel-permeant guanidinium analogue~1-amino-4-guanidobutane, AGB! and observed strong NMDA activation in only a subset of amacrine cells. GABAergic amacrine cells displayed a range of KA responses, whereas glycinergic amacrine cells were all driven by KA.
Previously, electrophysiological characterization of the GluRs expressed by amacrine cells has been hampered by a lack of specific agonists and antagonists of AMPA and KA receptors Wilding & Huettner, 1995!, allowing differentiation only between NMDA and non-NMDA receptors. These studies showed that NMDA receptors play only a minor role in the light responses of AII, A17, and starburst amacrine cells~Boos et al., 1993; Zhou & Fain, 1995; Hartveit & Veruki, 1997!. Recently, the availability of selective drugs such as cyclothiazide~Vyklicky Bertolino et al., 1993; Lodge, 1993!, GYKI 52466 and GYKI 53655~Donevan & Rogawski, 1993; Wilding & Huettner, 1995; Bleakman et al., 1996 ! and SYM 2081~Gu et al., 1995 Zhou et al., 1997; Donevan et al., 1998 ! allows differentiation between AMPA and KA receptors. Recordings from AII amacrine cells showed that the functional non-NMDA GluRs of AII amacrine cells were exclusively AMPA receptors~Mørkve et al., 2002; Veruki et al., 2003; Zhou & Dacheux, 2004 Hartveit & Veruki, 1997; Trexler et al., 2003; Zhou & Dacheux, 2004!. Taken together, the results from anatomy and physiology suggest that different amacrine cells signal through specific GluRs or combinations of GluRs. However, there is a mismatch between the physiological and anatomical results for KA and AMPA receptors. The aim of this paper was to further characterize the ionotropic GluRs expressed by amacrine cells. Whole-cell recordings were performed on slices of mouse retina and the pharmacological sensitivity of AMPA-, KA-, and NMDA-elicited currents was investigated. During recordings, cells were filled with a fluorescent marker to reveal their morphology. Some experiments were performed on retinal slices from a transgenic mouse, in which enhanced green fluorescent protein~EGFP! was expressed under the control of the glycine transporter GlyT2~Zeilhofer et al., 2005!, in order to selectively target different amacrine cell types.
Materials and methods

Preparation of retinal slices, visualization, and identification of amacrine cells
Wild-type~C57Bl6! and transgenic mice, aged 5-8 weeks, were used for the experiments. The transgenic mouse line carries the gene for green fluorescent protein~EGFP! driven by the GlyT2 promotor~Zeilhofer et al., 2005!. The mice were deeply anesthetized with isoflurane~CuraMED Pharma GmbH, Karlsruhe, Germany! and decapitated. All procedures were approved by the local animal care committee and were in accordance with the law for animal experiments issued by the German Government~Tiers-chutzgesetz!. The retinae were dissected free from the eyecup in Ames solution~Sigma-Aldrich, Taufkirchen, Germany! and were embedded in 2% agar dissolved in Ames medium~kept at 388C!. The resulting block was rapidly cooled and transferred to a microslicer~Dosaka EM Co., Japan!. 200-µm-thick slices were cut, which were then kept in Ames equilibrated with carbogen~95% O 2 and 5% CO 2 ! for 30 min before electrophysiological recording. The tissue could be maintained for up to 6 h in oxygenated Ames medium. The specimens were viewed by differential interference contrast~DIC! microscopy using a water immersion objectivẽ 63ϫ, Zeiss, Oberkochen, Germany! on a fixed stage, upright microscope~Axioskop, Zeiss!.
The experiments were done under laboratory light conditions, and consequently the retina was light adapted. In some cases the photoreceptors were bleached, because of the epifluorescence illumination used to find and patch EGFP-positive amacrine cells filter set Nr. 09; Zeiss, Oberkochen!. In general, to record from amacrine cells, we patched somata in the inner part of the inner nuclear layer~INL!.
Solutions and chemicals
The recording chamber was perfused at a rate of ;2 ml0min with bicarbonate-buffered carbogenated Ames solution~Sigma-Aldrich, Taufkirchen, Germany!. The intracellular solution contained in mM: Cs-gluconate 125.0, CaCl 2 1.0, EGTA 10.0, MgSO 4 4.6, Na-Hepes 10.0, NaATP 4.0, NaGTP 0.4, tetrabutylammonium~TBA! 5.0, Neurobiotin~Vector Laboratories, Burlingame, CA! 10.0, Lucifer Yellow~LY! or Alexa488~Molecular Probes, Göttingen, Germany! 0.1, pH ϭ 7.42 adjusted with 5.9 M CsOH. All transmitter agonists and antagonists were applied by local superfusion through a multibarrel, pressure-driven system~DAD12, ALA Scientific Instruments, Lambrecht, Germany! with a final tip diameter of 100 mm. The tip was placed ;50 mm from the cell. Hepesbuffered solution, used in the application system, contained in mM: NaCl 145, KCl 2.5, CaCl 2 2.0, MgCl 2 1.0, Na-Hepes 1.0, pH ϭ 7.4 adjusted with 1 M NaOH. For brevity, it will be called DAD solution for the rest of the manuscript. Puffing control solution alone did not evoke any currents. The liquid junction potential between intracellular and extracellular solutions was calculated to be 15 mV and was later subtracted from the raw data~Liquid junction potential calculator; Barry, 1994!. The drugs were prepared as stock solutions, in mM: glycine 1, AMPA 10, KA 25, NMDA 50, NBQX 5, cyclothiazide 10, D-AP5 100~Biotrend Tocris, Cologne, Germany!, GYKI 52466 10~Sigma-Aldrich!, GYKI 53655 10~kind gift of Dr. Carl Romano, Washington University, St. Louis, MS!, SYM 2081 10~Calbiochem, Bad Soden, Germany!, strychnine 1~Sigma-Aldrich!. For each experiment the drugs were freshly dissolved in filtered DAD solution. All other chemicals were purchased from Sigma-Aldrich. 
Patch-clamp recordings
Recordings were carried out at room temperature with an EPC-9 patch-clamp amplifier~HEKA Electronik, Lambrecht, Germany! and Pulse 8.11 software. The patch pipettes were pulled from borosilicate glass tubing~Hilgenberg, Malsfeld, Germany!. When filled with internal solution, they had a resistance of 7-9 MV. Cells were voltage-clamped in the whole-cell mode. Input resistances were ;1 GV. Series resistances were ;20 MV and were left uncompensated in most of the recordings. The cell and pipette capacitances were cancelled. The signals were filtered using the eight-pole Bessel filter built-in to the EPC-9 amplifier and digitized at a frequency of 0.5 kHz, which was at least twice the filter cutoff frequency. Donevan & Rogawski, 1993; Wilding & Huettner, 1995; Bleakman et al., 1996 !. Drugs were applied from a twelve-line superfusion system, through an application pipette with a diameter of 100 mm. The applications followed a standard sequence: basic agonist-basic agonist with selective agonist0antagonist-basic agonist~selective agonist0antagonist wash-out!. A thirteenth flush line, active between applications, ensured the removal of any previous drug left in the pipette tip before a new application. The time between applications ranged from 1.5 min to 2 min, to allow for receptor recovery from possible desensitization. Each sequence of drug applications was repeated several times to make sure that the effects were reproducible. Data analysis was subsequently carried out with IgorPro 4~WaveMetrics Inc., Lake Oswego, OR! using homemade routines and the statistics and graphs were completed in Excel~Microsoft!. Expression of NMDA, AMPA, and KA receptors was determined by analyzing the effects of the receptor-selective drugs on the current induced by the basic agonist. Agonist-induced currents were integrated over time resulting in total charge transported through the cell membrane. The charge transfers during the action of the agonist and the different antagonists were normalized to the control values and compared.
Experimental protocols and data analysis
Light microscopy
The cells expressing EGFP under the GlyT2 promoter were investigated in sections that were immunolabeled for GABA~Sigma, Taufkirchen, Germany!, 1:2000, rabbit anti GABA, and for the glycine transporter GlyT1~Chemicon, Temecula, CA! 1:5000, goat anti GlyT1. Standard immunocytochemical methods were used~Haverkamp et al., 2004!. The slices with LY or Alexa488-and Neurobiotin-filled cells were fixed for 30 min with 4% paraformaldehyde in 0.1 M phosphate buffer~PB! at room temperature and washed in phosphate buffer~PB! several times. Neurobiotin was visualized using Streptavidin Alexa488~1:2000; Molecular Probes, Göttingen, Germany!. The slices were mounted on a slide and examined on a confocal laser scanning microscope~Zeiss LSM Pascal! using a 40ϫ oil immersion objective. Stacks of confocal images were projected onto a single image plane. The size and contrast of the images were adjusted using Adobe Photoshop~Version 7.0!.
Results
Anatomical characterization of amacrine cells
Whole-cell recordings were made from amacrine cells in vertical slices of the mouse retina. The slices were viewed using DIC optics and in the majority of the recordings the electrode was directed to the cell bodies of amacrine cells in the INL without prelabeling them. The electrode was filled with LY and Neurobiotin or with Alexa488 and Neurobiotin, which diffused into the cells during the recordings. After the experiments, the injected cells were visualized with fluorescent streptavidin and photographed on a confocal microscope. Given that there are 30 different types of amacrine cells, it was not possible to unequivocally identify the cells a priori in the slices. This was only possible for AII amacrine cells~Fig. 1A!, while the remaining cells were grouped into narrow-field and wide-field cells. One wide-field cell, a putative A17 cell, is illustrated in Fig. 1B , a second wide-field cell with stratified dendrites is shown in Fig. 1C .
In later experiments, a transgenic mouse line in which EGFP is expressed in amacrine cells under the control of the GlyT2 promoter, was used~Zeilhofer et al., 2005!. Many amacrine cell bodies and their processes in the IPL showed strong expression of EGFP~Fig. 2!~Haverkamp et al., 2004!, which was unexpected, because previous immunocytochemical studies had shown that glycinergic amacrine cells express GlyT1 but not GlyT2~Zafra et al., 1995; Menger et al., 1998 !. In order to study the amacrine cell types expressing EGFP in the transgenic mice, we double labeled sections for EGFP and GlyT1~Figs. 2A & 2B! and found that 85% of the EGFP-labeled amacrine cells also express GlyT1. We also double labeled sections for EGFP and GABA~Figs. 2C & 2D! and observed 15% double-labeled cell bodies~arrowheads in Figs. 2C & 2D!. It was relatively easy to target the recording electrode to AII amacrine cells in the EGFP transgenic mice, because their primary dendritic trees were visible under fluorescence illumination~Fig. 2E!. In order to record GABAergic amacrine cells, we directed the electrode to cell bodies that did not express EGFP. For the recordings of glycinergic amacrine cells, EGFP-labeled cell bodies were recorded and filled with Alexa488. If they were small-field amacrine cells, they were classified as glycinergic amacrines.
AMPA-and KA-evoked currents of amacrine cells
Whole-cell currents were recorded from amacrine cells which were voltage clamped at Ϫ75 mV. Non-NMDA GluRs were activated by the application of AMPA and KA from a puffer pipette. Fig. 3A shows KA-induced currents of an amacrine cell at different holding potentials. The currents reversed at 0.7 6 5 mV and a current-voltage plot shows a linear relationship~Fig. 3B!.
Both AMPA-~Figs. 3C-3E! and KA-evoked currents~Figs. 3F-3H! could be reversibly blocked by the co-application of 10 mM NBQX. The linear current-voltage relation and their complete blockade by NBQX indicate that these currents are mediated by non-NMDA receptors.
For a more detailed analysis, cells were probed as shown in Fig. 4 . First AMPA was applied on its own~Fig. 4A!, next AMPA was applied together with CTZ~Fig. 4B! followed again by AMPA alone~Fig. 4C!. The AMPA-evoked current was increased and prolonged during the CTZ application suggesting that this cell expresses AMPA receptors. The same cell was further probed with KA~Figs. 4D-4F!. Application of KA induced a strong inward current that could be effectively blocked by the co-application of GYKI 52466, the selective AMPA receptor antagonist. In contrast, when KA was co-applied together with SYM 2081, the selective KA receptor agonist, no current changes could be observed with respect to the control~Figs. 4G-4I!. Finally, SYM 2081 was applied on its own~Fig. 4J! and no current was induced. Taken together these results suggest that the GluRs expressed by this amacrine cell are AMPA and not KA receptors.
We also found cells which preferentially expressed KA receptors~Fig. 5!. First, AMPA was applied~Fig. 5A!, followed by AMPA together with CTZ~Fig. 5B! and the control~Fig. 5C!. CTZ had only little effect on the AMPA-induced response. Next, the cell was probed with KA~Fig. 5D! and KA together with GYKI 52466~Fig. 5E! followed by the control~Fig. 5F!. GYKI was not able to block or even reduce the KA-evoked current. Finally, the selective KA receptor agonist SYM 2081 was tested Figs. 5G-5I!, occluding most of the KA-induced current~Fig. 5H!. SYM 2081 applied alone induced a small inward current. Amacrine cells showing this pharmacological profile were considered to express KA but not AMPA receptors.
In most amacrine cells, we observed mixed responses, partially mediated by AMPA and partially by KA receptors. Such a cell is illustrated in Fig. 6 . The current elicited by the application of AMPA~Fig. 6A! is greatly enhanced by the co-application of CTZ Fig. 6B !. The AMPA-induced current is also greatly reduced by the application of GYKI 52466~Fig. 6E!. Both results suggest activation of AMPA receptors in this cell. Interestingly, when KA was applied~Figs. 6G-6I!, co-application of SYM 2081 did not cause much reduction of the peak current although a faster deactivation was observed and the total charge transfer was reduced by 23%~Fig. 6H!. This reduction was completely reversible~Fig. 6I!. In addition, application of SYM 2081 alone elicited a small inward current~Fig. 6J!. These results suggest that this cell also expresses KA receptors. The recordings shown in Fig. 6 also indicate that a more quantitative definition of the AMPA0KA pharmacology is needed.
In recent studies of the retina, GluRs could be separated into AMPA and KA subtypes~Shen et al., 1999; DeVries, 2000; Mørkve et al., 2002; Singer & Diamond, 2003; Veruki et al., 2003; Shen et al., 2004 !. Paired recordings from cones and OFF cone bipolar cells enabled DeVries to study the pharmacological profiles of AMPA and KA receptors separately in different bipolar cells. Shen and coworkers~2004! studied the GluR of cultured human horizontal cells and found that they express both AMPA and KA receptors.
In this study, the expression of AMPA receptors was assumed when the following two conditions were fulfilled:~1! the total charge transported following application of AMPA was increased to 125% or more during the co-application of CTZ;~2! the total charge transported by the application of KA was reduced by the 82 O.N. Dumitrescu et al. co-application of GYKI 52466 to less than 75% or by GYKI 53655 to less than 85%. The expression of KA receptors was assumed when the following two conditions were fulfilled:~1! more than 25% of the total charge transported at the application of KA were left during the co-application of GYKI 52466 or 53655;~2! less than 90% of the total charge transported at the application of KA were left during the co-application of SYM 2081. Based on these criteria, the expression of AMPA and KA receptors by the different amacrine cell types recorded in this study followed the pattern illustrated in Fig. 7 . The majority~77%! of AII amacrine cells tested~n ϭ 13! expressed AMPA and KA receptors whilst 23% of them exclusively expressed AMPA receptors. No AII cells were found to express only KA receptors.
In the case of narrow-field amacrine cells~n ϭ 27!~Fig. 7, NF!, 70% were found to express both AMPA and KA receptors, in 7% only AMPA receptors were found, while in 22% KA receptors were observed exclusively.
In the case of wide-field amacrine cells~n ϭ 14!~Fig. 7, WF!, only 43% were found to co-express AMPA and KA receptors, 36% expressed solely AMPA, and 21% only KA receptors.
As described above, the amacrine cells recorded in the GlyT2-EGFP transgenic mouse retina were subdivided into glycinergic and GABAergic cells~Fig. 7, GLY and GABA!. Of the GABAergic cells~n ϭ 6!, 67% expressed AMPA as well as KA receptors, while 33% exclusively expressed KA receptors. Similarly, 81% of the glycinergic cells~n ϭ 16! expressed AMPA as well as KA receptors, while 19% exclusively expressed KA receptors.
The relative contributions of AMPA and KA receptors to the total response varied among the different amacrine cell types. Fig. 8 shows the reduction of the KA-induced currents by the co-application of GYKI 52466. In the case of AII cells, the total charge transported was reduced to an average of 50 6 4%~n ϭ 5! and showed little variation among the cells~Fig. 8A!. In the case of narrow-field amacrine cells the reduction was to 70 6 26%~n ϭ 15! and there was much variation between the cells~Fig. 8B!. In wide-field amacrine cells, the average reduction was to 51 6 24% n ϭ 11! and the variation between the cells was substantial Fig. 8C !.
NMDA-evoked currents of amacrine cells
We also tested amacrine cells for expression of NMDA receptors Fig. 9 !. The cells were clamped to Ϫ75 mV and NMDA was applied at a concentration of 100 or 500 mM in the presence of small amounts of the co-agonist glycine~2 mM! and strychninẽ 1 mM!, to prevent activation of glycine receptors. The Mgconcentration of the bath solution was 1.2 mM, however, in the puffer pipette solution no Mg was included in order to reduce the Mg-block of NMDA receptors at hyperpolarizing potentials. Under these circumstances, small responses~Fig. 9C!, which were reversibly blocked by the co-application of AP5~Figs. 9D & 9E!, could be observed. When the NMDA-evoked currents were measured at different holding potentials~Fig. 9A!, they showed the typical nonlinear current-voltage relation of NMDA receptors Fig. 9B !. This indicates that partial magnesium block of the NMDA receptors remained. NMDA-evoked currents could not be blocked by the application of NBQX~Figs. 9F-9H!. In accordance with this, AMPA-and KA-induced currents could not be blocked by AP5~Figs. 9I-9K!.
In all cells tested, the NMDA-evoked currents were significantly smaller than the AMPA-and KA-evoked responses. However, they might have been underestimated when recording at Ϫ75 mV, because of the incomplete removal of the Mg 2ϩ blockadẽ Fig. 9B !. Even at depolarizing potentials their amplitudes reached In this and all following graphs, the horizontal bar represents the time during which the drugs were ejected from the puffer pipette. B, current-voltage relation of KA-evoked currents~average of 7 cells!. C, current evoked by the application of AMPA. D, coapplication of AMPA and NBQX blocked this current. E, recovery. F, current evoked by the application of KA. G, co-application of KA and NBQX blocked this current. H, recovery.
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O.N. Dumitrescu et al. 80 pA in the best cases. We have not encountered any cells that exclusively express NMDA receptors. Application of 100 mM NMDA elicited small responses in most wide-field and half of the narrow-field amacrine cells tested, but no AII amacrine cells showed NMDA-mediated currents under these conditions. When the concentration of NMDA was increased to 500 mM and the holding potential switched to depolarized values~35 to 45 mV!, NMDA responses could be measured in most wide-field, in about half of the narrow-field cells, and in 3 out of 12 AII amacrine cells. These results are illustrated in more detail in the summary diagram in Fig. 10 . There appears to be a difference with respect to the expression of NMDA receptors among the cell populations investigated: the majority of wide-field amacrine cells~WF, GABA in Fig. 10 ! express NMDA receptors, while less than half of the narrow-field amacrine cells~AII, NF and GLY in Fig. 10 ! show NMDA responses.
Discussion
Are there amacrine cells that express exclusively AMPA or KA receptors?
It has been shown for OFF cone bipolar cells that two types~b3, b7! express exclusively KA receptors at their cone contacts, while one type~b2! receives its cone input only via AMPA receptors DeVries, 2000!. In the case of horizontal cells, it was found that they express both AMPA and KA receptors~Shen et al., 2004!. Because of the high number of different amacrine cell types the encounter rate of a given type was very low. Some of the amacrine cell types make up less than 1% of the amacrine population and, therefore, might not have been recorded from at all in our study. Nonetheless we observed convincing examples of cells that expressed exclusively AMPA~Fig. 4! or KA receptors~Fig. 5!. Such cells were more often found amongst the population of wide-field cells. Because of the high number of different amacrine cells, we could only study their GluRs by puffing agonist and it is difficult to asign synaptic roles to the receptors mediating the puff-evoked responses. Clearly, studies of spontaneous synaptic currents~sEP-SCs! and of paired recordings of presynaptic and postsynaptic neurons are the method choice for a more detailed analysis of synaptic receptors~Mørkve et al., 2002; Veruki et al., 2003; Singer & Diamond, 2003!. The synaptic localization of both AMPA and KA receptors in the IPL has also been studied by immunocytochemical methods in the rodent, cat, and primate retina. All four AMPA subunits GluR1-4! have been described in postsynaptic processes of bipolar cell dyads. Usually only one of the two postsynaptic processes expressed AMPA receptors~Qin & Pourcho, 1996, 1999a,b; , 1994; Fletcher et al., 2000; Grünert et al., 2002!. These results predict that the two different postsynaptic processes at bipolar cell dyads express different sets of GluRs. Light microscopy studies have shown that the different GluRs have a distinctly stratified distribution across the IPL. The same holds true for the axon terminals of bipolar cells~Grünert et al., 2003! and the processes of many amacrine cell types.
All this, together with our findings predicts a selective wiring between bipolar cells and amacrine cells and also a specific expression of GluRs at the dyads. More work is needed, however, before the functional role of such specific expression of GluRs by amacrine cells can be understood. One prerequisite for such experiments is that particular types of amacrine and possibly bipolar cells are pre-labeled by EGFP or other markers, so they can be selected for the recordings and the subsequent analysis of their GluRs, an approach that in our experiments proved to be very helpful.
Ionotropic glutamate receptors of AII and AI amacrine cells
Signal transmission at the rod bipolar r AII0AI dyad plays a crucial role in scotopic vision, in which AII amacrine cells mediate the direct signaling pathway, whilst AI cells play a modulatory role providing inhibitory feedback to the rod bipolar cells. Thus, it is logical to expect that these amacrine cells express glutamate AII amacrine cells. They report that 6-cyano-7-nitroquinoxaline-2,3-dione~CNQX! blocks the transmission, however, they did not study the GluRs expressed at this synapse in more detail. Habermann et al.~2001! showed that in AII cells, glutamate-induced Ca-entry occurred at the arboreal dendrites~rod bipolar input! but not at the lobular dendrites~OFF cone bipolar input!. It is therefore possible that AII amacrine cells express different GluRs at these two synaptic sites. In the present study, we found that most AII cells express both AMPA and KA receptors, and it appears to be an attractive idea that AMPA receptors mediate the signal transfer from rod bipolar to AII cells, while KA receptors are involved with the signal transfer from OFF cone bipolar cells to AII cells. In the case of rat AI~A17! amacrine cells, AMPA-and KAinduced currents could be blocked by CNQX~Menger & Wässle, 2000!. Furthermore, light-evoked ON-responses were also blocked by 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo~f!quinoxaline~NBQX! and they were resistant to the NMDA receptor antagonist 3-~2-carboxypiperazin-4-yl!propyl-1-phosphonic acid~CPP!. In paired recordings from rod bipolar and AI amacrine cells, Singer and Diamond~2003! observed AMPA receptor-mediated EPSCs in the AI cells. Surprisingly, immunocytochemical studies of the rod bipolar cell dyad reported the AMPA receptor subunits GluR203 and GluR4 in the AII but not in the AI cells~Ghosh et al., 2001; Li et al., 2002!. In contrast, the d102 subunits were observed in AI cells. In the rabbit retina, AI cells represent two types, S1 and S2, and it was shown that only S1 cells express the d102 subunits~Li et al., 2002!. Hence, it is difficult to match the physiological results postulating AMPA receptors with the immunocytochemical results demonstrating the absence of AMPA, but suggesting the presence of other GluRs.
The diverse results regarding AII and AI cells highlight the difficulties in reconciling the pharmacological0physiological results with the molecular0immunocytochemical results. One reason might be that the pharmacological profiles of the different GluR subunits have mostly been identified in artificial expression systems~HEK 293 cells or oocytes!, while in retinal neurons combinations of GluR subunits are found in postsynaptic densities that may escape such a clear cut pharmacological analysis. Nevertheless, the marked difference in the proportion of GluRs expressed by AII and WF amacrine cells reported in our study support the current view that different types of glutamate receptors are expressed at this dyadic synapse.
Ionotropic glutamate receptors of cholinergic amacrine cells
The The aforementioned examples of AII, AI, and cholinergic amacrine cells show that multiple GluRs are present in amacrine cells. They also show that the same amacrine cell type can express different GluRs that subserve different functions, such as the transfer of the light signal, or a more modulatory role. AII cells are the crucial interneurons in conducting the rod signal through the retina, while cholinergic amacrine cells are involved with processing information concerning moving and rapidly changing stimuli. Thus, it seems plausible that they both express the rapidly desensitizing AMPA receptors that allow the transfer of light signals with high temporal resolution.
Most other amacrine cells have more modulatory roles and are not involved with the direct transfer of the light signals. Glycinergic amacrine cells usually have narrow and vertically oriented dendritic fields. They are involved in more local operations such as interactions between the OFF-and ON-channels~Wässle, 2004!. GABAergic amacrine cells are mostly wide-field cells, often narrowly stratified~in one lamina!, and they are involved with spatial operations such as center-surround interactions. In the following, we will discuss how the GluR expression can be correlated with the functional roles of amacrine cells. 
Ionotropic receptors of other amacrine cells
There appears to be a difference in our results if the expression of NMDA receptors~Fig. 9! is considered. Out of 15 narrow-field and two glycinergic amacrine cells tested, only seven cells showed NMDA-mediated responses. In contrast, ten out of 13 wide-field and two out of three GABAergic cells were found to express NMDA receptors. This result is in agreement with previous studies on amacrine cell light responses. In the tiger salamander retina, Dixon and Copenhagen~1992! found that transient amacrine cells express NMDA receptors, while sustained amacrine cells do not. In B, current-voltage relation~average of 3 cells, reversal potential Ϫ5 6 1.2 mV!. The Mg-block at negative holding potentials is not complete, because NMDA was applied in Mg-free solution from the puffer pipette. C, inward current induced by the application of NMDA. D, co-application of NMDA with AP5 effectively blocked the current. E, recovery. F, application of NMDA elicited an outward current at V H ϭ ϩ45 mV.. G, this current could not be blocked by the co-application of NMDA and NBQX. H, recovery. I, application of KA induced a prominent inward current. J, co-application of KA and AP5 did not block this current. K, recovery.
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O.N. Dumitrescu et al. receptor antagonists block them completely~Slaughter & Miller, 1983; Massey & Miller, 1988; Dixon & Copenhagen, 1992!. Most amacrine cells expressed AMPA receptors. Thus, 87% of the narrow-field~n ϭ 45!, 85% of the glycinergic~n ϭ 20!, 81% of the wide-field~n ϭ 21!, and 78% of the GABAergic cells~n ϭ 9! showed AMPA receptor-mediated responses. AMPA receptor expression in amacrine cells of different retinae is well established, by both immunocytochemical and physiological studies~reviewed by Thoreson & Witkovsky, 1999 !. In fact, most of these studies also reported that AMPA receptors are the dominant GluRs of amacrine cells~tiger salamander: Maguire, 1999; Tran et al., 1999; carp: Shen et al., 1999; rat: Singer & Diamond, 2003; rabbit: Firth et al., 2003; turtle: Vigh & Witkovsky, 2004 !. In our sample, a great variability existed among the individual cell responses to AMPA selective drugs. In each group, we recorded cells where CTZ strongly potentiated the AMPA-evoked current and GYKI strongly inhibited it, other cells in which the two drugs had very little effect, as well as many intermediate cases.
We found that most amacrine cells express KA receptors as well. Thus, 93% of the narrow-field~n ϭ 43!, 95% of the glycinergic~n ϭ 16!, 85% of the wide-field~n ϭ 26!, and all of the GABAergic cells~n ϭ 6! tested showed KA receptor-mediated responses. Although KA receptor subunits have been found by immunocytochemistry throughout the IPL of the mammalian retinã rat: Brandstätter et al., 1994 Brandstätter et al., , 1997 cat: Qin & Pourcho, 2001; mouse: Haverkamp & Wässle, 2000; monkey: Grünert al., 2002!, to our knowledge this is the first study to report KA receptor activity in amacrine cells. However, comparable to the expression of AMPA receptors we also observed a great variability in the expression of KA receptors.
